Valion Bio, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Valion Bio, Inc. (VBIO) had Common Stock, Capital Shares Reserved for Future Issuance of 42.72 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-14
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 42.72M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 28.58M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.28M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 4.58M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 42.72M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 28.58M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 20.28M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 4.58M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 1.34M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 821.39K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 721.66K shares 10-K · filed 2026-03-30 | |
| 2024-09-30 | 13.02M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 12.11M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 146.65K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 4.79K shares 10-K · filed 2025-03-21 | 81.35K shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 81.35K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 3.46M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 3.46M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 19.99K shares 10-K · filed 2024-03-25 | 2.00M shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 2.00M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 2.05M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 2.07M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 1.59M shares 10-K · filed 2023-03-31 | 1.59M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |